Delivery of Therapeutic Proteins via Extracellular Vesicles: Review and Potential Treatments for Parkinson’s Disease, Glioma, and Schwannoma

[1]  X. Breakefield,et al.  Introduction to Extracellular Vesicles: Biogenesis, RNA Cargo Selection, Content, Release, and Uptake , 2016, Cellular and Molecular Neurobiology.

[2]  M. Chopp,et al.  Exosomes as Tools to Suppress Primary Brain Tumor , 2016, Cellular and Molecular Neurobiology.

[3]  P. Lichter,et al.  Exosomes released by chronic lymphocytic leukemia cells induce the transition of stromal cells into cancer-associated fibroblasts. , 2015, Blood.

[4]  M. Wood,et al.  Therapeutic Potential of Multipotent Mesenchymal Stromal Cells and Their Extracellular Vesicles. , 2015, Human gene therapy.

[5]  J. Silke,et al.  Fight or flight: regulation of emergency hematopoiesis by pyroptosis and necroptosis , 2015, Current opinion in hematology.

[6]  Christian Pilarsky,et al.  Glypican-1 identifies cancer exosomes and detects early pancreatic cancer , 2015, Nature.

[7]  Richa Gupta,et al.  Exosomes as drug delivery vehicles for Parkinson's disease therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[8]  J. Meldolesi,et al.  Ectosomes and exosomes: shedding the confusion between extracellular vesicles. , 2015, Trends in cell biology.

[9]  H. Qian,et al.  Exosomes Derived from Human Umbilical Cord Mesenchymal Stem Cells Relieve Acute Myocardial Ischemic Injury , 2015, Stem cells international.

[10]  Jacco van Rheenen,et al.  In Vivo Imaging Reveals Extracellular Vesicle-Mediated Phenocopying of Metastatic Behavior , 2015, Cell.

[11]  Michael A. Hollingsworth,et al.  Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver , 2015, Nature Cell Biology.

[12]  A. M. Belov,et al.  Mass-spectrometry-based molecular characterization of extracellular vesicles: lipidomics and proteomics. , 2015, Journal of proteome research.

[13]  Ralph Weissleder,et al.  Visualization and tracking of tumour extracellular vesicle delivery and RNA translation using multiplexed reporters , 2015, Nature Communications.

[14]  I. Nakano,et al.  Extracellular vesicles in the biology of brain tumour stem cells--Implications for inter-cellular communication, therapy and biomarker development. , 2015, Seminars in cell & developmental biology.

[15]  Christopher H Contag,et al.  Differential fates of biomolecules delivered to target cells via extracellular vesicles , 2015, Proceedings of the National Academy of Sciences.

[16]  Joshua N Leonard,et al.  Therapeutic applications of extracellular vesicles: clinical promise and open questions. , 2015, Annual review of pharmacology and toxicology.

[17]  Imre Mäger,et al.  Extracellular vesicle in vivo biodistribution is determined by cell source, route of administration and targeting , 2015, Journal of extracellular vesicles.

[18]  Y. Mo,et al.  Exosome-mediated transfer of miR-10b promotes cell invasion in breast cancer , 2014, Molecular Cancer.

[19]  B. Roizman,et al.  Cells infected with herpes simplex virus 1 export to uninfected cells exosomes containing STING, viral mRNAs, and microRNAs , 2014, Proceedings of the National Academy of Sciences.

[20]  Y. Gho,et al.  Extracellular vesicles as emerging intercellular communicasomes , 2014, BMB reports.

[21]  S. Kwiatkowski,et al.  Multiple faces of children and juvenile meningiomas: A report of single-center experience and review of literature , 2014, Clinical Neurology and Neurosurgery.

[22]  P. Robbins,et al.  Regulation of immune responses by extracellular vesicles , 2014, Nature Reviews Immunology.

[23]  Jian Song,et al.  A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. , 2014, Biomaterials.

[24]  Maria Ericsson,et al.  Dynamic biodistribution of extracellular vesicles in vivo using a multimodal imaging reporter. , 2014, ACS nano.

[25]  Jeff S. Schorey,et al.  Exosomes carrying mycobacterial antigens can protect mice against Mycobacterium tuberculosis infection , 2013, European journal of immunology.

[26]  L. Mincheva-Nilsson,et al.  Exosomes Secreted by Human Placenta Carry Functional Fas Ligand and TRAIL Molecules and Convey Apoptosis in Activated Immune Cells, Suggesting Exosome-Mediated Immune Privilege of the Fetus , 2013, The Journal of Immunology.

[27]  Shu Zhang,et al.  Preformed albumin corona, a protective coating for nanoparticles based drug delivery system. , 2013, Biomaterials.

[28]  D. Tang,et al.  Regulation of the Tumor Suppressor PTEN through Exosomes: A Diagnostic Potential for Prostate Cancer , 2013, PloS one.

[29]  R. Welti,et al.  Grape exosome-like nanoparticles induce intestinal stem cells and protect mice from DSS-induced colitis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[30]  R. Khokha,et al.  Proteolytic factors in exosomes , 2013, Proteomics.

[31]  Imre Mäger,et al.  Extracellular vesicles: biology and emerging therapeutic opportunities , 2013, Nature Reviews Drug Discovery.

[32]  T. Conlon,et al.  Regression of schwannomas induced by adeno-associated virus-mediated delivery of caspase-1. , 2013, Human gene therapy.

[33]  P. Hainaut,et al.  Tumor-cell-derived microvesicles as carriers of molecular information in cancer , 2013, Current opinion in oncology.

[34]  P. Altevogt,et al.  Vesiclepedia: A Compendium for Extracellular Vesicles with Continuous Community Annotation , 2012, PLoS biology.

[35]  M. Rubin,et al.  Large oncosomes in human prostate cancer tissues and in the circulation of mice with metastatic disease. , 2012, The American journal of pathology.

[36]  Mehmet Fatih Bolukbasi,et al.  Genetically Engineered Microvesicles Carrying Suicide mRNA/Protein Inhibit Schwannoma Tumor Growth , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.

[37]  R. Setterquist,et al.  Exosomes: current knowledge of their composition, biological functions, and diagnostic and therapeutic potentials. , 2012, Biochimica et biophysica acta.

[38]  Gema Moreno-Bueno,et al.  Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET , 2012, Nature Medicine.

[39]  X. Breakefield,et al.  Role of Exosomes/Microvesicles in the Nervous System and Use in Emerging Therapies , 2012, Front. Physio..

[40]  Stanley N Cohen,et al.  Formation and release of arrestin domain-containing protein 1-mediated microvesicles (ARMMs) at plasma membrane by recruitment of TSG101 protein , 2012, Proceedings of the National Academy of Sciences.

[41]  Bo Li,et al.  RhoA triggers a specific signaling pathway that generates transforming microvesicles in cancer cells , 2012, Oncogene.

[42]  Meredith C Henderson,et al.  The Genomic and Proteomic Content of Cancer Cell-Derived Exosomes , 2011, Front. Oncol..

[43]  J. Le Pecq,et al.  Increasing vaccine potency through exosome antigen targeting. , 2011, Vaccine.

[44]  Clotilde Théry,et al.  Exosomes: immune properties and potential clinical implementations , 2011, Seminars in Immunopathology.

[45]  T. Wurdinger,et al.  LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF‐κB activation , 2011, The EMBO journal.

[46]  C. Kim,et al.  Introduction of the CIITA gene into tumor cells produces exosomes with enhanced anti-tumor effects , 2011, Experimental & Molecular Medicine.

[47]  G. Ayers,et al.  Amphiregulin Exosomes Increase Cancer Cell Invasion , 2011, Current Biology.

[48]  M. Wood,et al.  Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes , 2011, Nature Biotechnology.

[49]  Jared L. Johnson,et al.  Cancer cell-derived microvesicles induce transformation by transferring tissue transglutaminase and fibronectin to recipient cells , 2011, Proceedings of the National Academy of Sciences.

[50]  Beiyi Shen,et al.  Protein Targeting to Exosomes/Microvesicles by Plasma Membrane Anchors* , 2011, The Journal of Biological Chemistry.

[51]  A. Stemmer-Rachamimov,et al.  A novel imaging-compatible sciatic nerve schwannoma model , 2011, Journal of Neuroscience Methods.

[52]  K. Vickers,et al.  MicroRNAs are Transported in Plasma and Delivered to Recipient Cells by High-Density Lipoproteins , 2011, Nature Cell Biology.

[53]  Alexander M Seifalian,et al.  The application of exosomes as a nanoscale cancer vaccine , 2010, International journal of nanomedicine.

[54]  Bai-Cheng He,et al.  Exosomes derived from IL-12-anchored renal cancer cells increase induction of specific antitumor response in vitro: a novel vaccine for renal cell carcinoma. , 2009, International journal of oncology.

[55]  M. Wewers,et al.  Monocyte Derived Microvesicles Deliver a Cell Death Message via Encapsulated Caspase-1 , 2009, PloS one.

[56]  J. Gusella,et al.  NF2/Merlin Is a Novel Negative Regulator of mTOR Complex 1, and Activation of mTORC1 Is Associated with Meningioma and Schwannoma Growth , 2009, Molecular and Cellular Biology.

[57]  D. Bigner,et al.  Proteomic and immunologic analyses of brain tumor exosomes , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[58]  R. Simpson,et al.  Proteomic profiling of exosomes: Current perspectives , 2008, Proteomics.

[59]  Johan Skog,et al.  Glioblastoma microvesicles transport RNA and protein that promote tumor growth and provide diagnostic biomarkers , 2008, Nature Cell Biology.

[60]  A. Guha,et al.  Intercellular transfer of the oncogenic receptor EGFRvIII by microvesicles derived from tumour cells , 2008, Nature Cell Biology.

[61]  C. Théry,et al.  Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responses. , 2008, Cancer research.

[62]  Vincenza Dolo,et al.  Tumor vesicle-associated CD147 modulates the angiogenic capability of endothelial cells. , 2007, Neoplasia.

[63]  R. Bertina,et al.  Microparticle‐associated tissue factor activity: a link between cancer and thrombosis? , 2007, Journal of thrombosis and haemostasis : JTH.

[64]  J. Ingwall,et al.  Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[65]  L. Zitvogel,et al.  Chemoimmunotherapy of Tumors: Cyclophosphamide Synergizes with Exosome Based Vaccines1 , 2006, The Journal of Immunology.

[66]  M. Behari,et al.  Erythrocyte antioxidant enzymes in Parkinson's disease. , 2005, The Indian journal of medical research.

[67]  J. Lavail,et al.  The microvesicle as a vehicle for EMMPRIN in tumor–stromal interactions , 2004, Oncogene.

[68]  G. Barber,et al.  The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene. , 2003, Cancer research.

[69]  M. Vila,et al.  NADPH oxidase mediates oxidative stress in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine model of Parkinson's disease , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[70]  Xiankui Li,et al.  Establishment and characterization of a schwannoma cell line from a patient with neurofibromatosis 2. , 2002, International journal of oncology.

[71]  N. Hirashima,et al.  Dynamics of intracellular granules with CD63-GFP in rat basophilic leukemia cells. , 2001, Journal of biochemistry.

[72]  H. Brühl,et al.  Transfer of the chemokine receptor CCR5 between cells by membrane-derived microparticles: A mechanism for cellular human immunodeficiency virus 1 infection , 2000, Nature Medicine.

[73]  M. Ebadi,et al.  Oxidative stress and antioxidant therapy in Parkinson's disease , 1996, Progress in Neurobiology.

[74]  B. Yankner,et al.  Apoptosis and increased generation of reactive oxygen species in Down's syndrome neurons in vitro , 1995, Nature.

[75]  C. Richards,et al.  Metabolism of 5-fluorocytosine to 5-fluorouracil in human colorectal tumor cells transduced with the cytosine deaminase gene: significant antitumor effects when only a small percentage of tumor cells express cytosine deaminase. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[76]  R. Blaese,et al.  Tumors expressing the cytosine deaminase suicide gene can be eliminated in vivo with 5-fluorocytosine and induce protective immunity to wild type tumor. , 1994, Cancer research.

[77]  Peter Riederer,et al.  Transition Metals, Ferritin, Glutathione, and Ascorbic Acid in Parkinsonian Brains , 1989, Journal of neurochemistry.

[78]  P. Mcgeer,et al.  Reactive microglia are positive for HLA‐DR in the substantia nigra of Parkinson's and Alzheimer's disease brains , 1988, Neurology.

[79]  P. Stahl,et al.  Receptor-mediated endocytosis of transferrin and recycling of the transferrin receptor in rat reticulocytes , 1983, The Journal of cell biology.

[80]  M. V. Van Woert,et al.  Brain peroxidase and catalase in Parkinson disease. , 1975, Archives of neurology.

[81]  D. Rall,et al.  Studies on the chemotherapy of experimental brain tumors: development of an experimental model. , 1970, Cancer research.

[82]  S. Plotkin,et al.  The Neurofibromatoses. Part 1: NF1. , 2009, Reviews in neurological diseases.